We’ve been keeping a running narrative of various market projections in telehealth, eHealth and mHealth–the most recent being Juniper Research’s 2014 mobile healthcare global estimate of $1.9 billion–but if you haven’t seen and bookmarked Brian Dolan’s bar graph comparison at Mobihealthnews, you should. … Read moreForecasts, forecasts…where do they end for mHealth?
A paper presented at the 2010 Second International Conference on eHealth, Telemedicine, and Social Medicine, St. Maarten, Netherlands Antilles in February confirms what has long been suspected: people with pendant alarms (medical alerts/PERS) wear them less often than would be optimal for their safety. Researchers Andrea Taylor and Stefan Agamanolis of Distance Lab, in Evaluation of the User Experience of a Standard Telecare Product – The Personal Trigger (etelemed, pp.51-56) surveyed over 1,300 clients who were using the leading UK manufacturer’s ‘Personal Trigger’, as they prefer to call the pendant alarm, in North East Scotland. They had a 60% response rate and the abstract tells us that…
I suppose that ‘certified’ is much more widely used in the US to mean ‘approved’ than it is in the UK where its strong association with ‘certified insane’ (in old speak) means that it is much less widely used except… Read moreContinua's certified products list
A great quote from a telehealth user as the BBC picks up on Cornwall’s intended continuation and extension of its telehealth service roll out following the Whole System Demonstrator (WSD) project. Previous Telecare Aware report.
Proteus Biomedical, best known here for ‘chip pills’ that monitor medication compliance (13 January, 9 February, more), just received FDA 510(k) approval for their Raisin Personal Monitor, a wearable device for remote recording and analysis of heart rate, physical activity, body… Read moreProteus Biomedical gains FDA approval for telehealth monitor
